Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Credit agrmnt [a]
|
|
Ortho Clinical Diagnostics Holdings plc
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/27/2022 |
8-K
| Quarterly results |
| 05/26/2022 |
8-K
| Quarterly results |
| 05/20/2022 |
8-K
| Quarterly results |
| 05/20/2022 |
8-K/A
| Quarterly results |
| 05/19/2022 |
8-K/A
| Quarterly results |
| 05/18/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
8-K
| Quarterly results |
| 05/06/2022 |
8-K
| Quarterly results |
| 05/04/2022 |
8-K
| Quarterly results |
| 04/07/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"ORTHO-CLINICAL DIAGNOSTICS HOLDINGS PLC 2021 EQUITY INCENTIVE PLAN 2014 Equity Incentive Plan OMNIBUS AMENDMENT TO AWARD AGREEMENTS This Omnibus Amendment to Award Agreements amends those outstanding award agreements described below relating to share option awards, restricted share units and restricted shares granted by Ortho Clinical Diagnostics Holdings plc or its predecessors under the Company’s 2014 Equity Incentive Plan or the Company’s 2021 Equity Incentive Plan . Capitalized terms not defined herein shall have the meanings set forth in the respective Plan. This Amendment does not, however, amend the terms of, and does not apply to, any Award that is covered by an individual amendment or similar agreement addressing the impact of the Combinations thereon. WHEREAS, the Company has ent...",
"ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC",
"Restricted Stock Agreement Amendment",
"AMENDED AND RESTATED SPECIAL ADVISOR AGREEMENT THIS AMENDED AND RESTATED SPECIAL ADVISOR AGREEMENT is made and entered as of April 3, 2022 , by and between Coronado Topco, Inc., a Delaware corporation , and Christopher Smith, an individual . BACKGROUND A. On December 22, 2021, the Company entered into a Business Combination Agreement by and among the Company, Ortho Clinical Diagnostics Holdings plc , Quidel Corporation and certain other parties, which provides for the acquisition of Quidel and Ortho by the Company . B. Smith currently serves as the Chairman and Chief Executive Officer of Ortho. C. The Company desires that Smith cease to serve as Chief Executive Officer and commence service as Special Advisor effective upon the consummation of the transactions contemplated by the BCA . D. S..." |
|
| 02/16/2022 |
8-K
| Quarterly results |
| 02/16/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"SPECIAL ADVISOR AGREEMENT THIS SPECIAL ADVISOR AGREEMENT is made and entered as of February 15, 2022, by and between Coronado Topco, Inc., a Delaware corporation , and Christopher Smith, an individual . BACKGROUND 1. On December 22, 2021, the Company entered into a Business Combination Agreement by and among the Company, Ortho Clinical Diagnostics Holdings plc , Quidel Corporation and certain other parties, which provides for the acquisition of Quidel and Ortho by the Company . 2. Smith currently serves as the Chairman and Chief Executive Officer of Ortho. 3. The Company desires that Smith cease to serve as Chief Executive Officer and commence service as Special Advisor effective upon the consummation of the transactions contemplated by the BCA . 4. Smith has previously entered into an Ame..." |
|
| 02/14/2022 |
8-K
| Other Events Interactive Data |
| 01/24/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 01/18/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/11/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 01/06/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 12/23/2021 |
8-K
| Quarterly results |
| 11/03/2021 |
8-K
| Quarterly results |
| 09/14/2021 |
8-K
| Quarterly results |
| 09/09/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 09/07/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/04/2021 |
8-K
| Quarterly results |
| 06/15/2021 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 05/25/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/11/2021 |
8-K
| Unregistered Sales of Equity Securities |
| 05/05/2021 |
8-K
| Quarterly results |
| 03/18/2021 |
8-K
| Quarterly results |
| 02/23/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/09/2021 |
8-K
| Credit agreement amendment|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : February 5, 2021 ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC England and Wales 001-39956 98-1574150 1001 Route 202, Raritan, New Jersey 08869 Registrant's telephone number, including area code: 218-8000 Not Applicable",
"Amendment No. 5 to the Credit Agreement, by and among Ortho-Clinical Diagnostics, Inc., Ortho-Clinical Diagnostics S.A., Ortho-Clinical Diagnostics Holdings Luxembourg S.à r.l., the lenders party thereto and Barclays Bank PLC, as administrative agent and collateral agent",
"Ortho Clinical Diagnostics Amends Credit Agreement to Extend Maturity and Increase Borrowing Capacity Under its Revolving Credit Facility" |
|
| 02/04/2021 |
8-K
| Asset disposition |
|
|